Lipitor, Crestor Covered With Low, No Copays In Universal American Part D Plans For 2011
This article was originally published in The Pink Sheet Daily
Executive Summary
With the patent expiration of Pfizer's Lipitor in sight, creative payer contracting by Pfizer and Crestor marketer AstraZeneca is coming to light as one national Medicare Part D plan announces it is offering a new deal on both brands next year.